quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:30:00·66d
PRRelease
Bio-Techne Corp logo

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories

TECH· Bio-Techne Corp
Health Care
Original source

Companies

  • TECH
    Bio-Techne Corp
    Health Care

Recent analyst ratings

  • Sep 3UpdateRBC Capital Mkts$73.00
  • Aug 21UpdateCitigroup$70.00
  • Jul 22UpdateStephens$65.00
  • Jul 9UpdateTD Cowen$65.00
  • May 30UpdateWells Fargo$59.00
  • Apr 9UpdateKeyBanc Capital Markets-

Related

  • INSIDER7d
    SEC Form 4 filed by Kelderman Kim
  • PR7d
    Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
  • PR10d
    Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results
  • INSIDER16d
    SEC Form 4 filed by Bohnen Shane
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Bio-Techne Corp
  • PR30d
    Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite
  • INSIDER50d
    SEC Form 4 filed by President - Diag & Spatial Bi Crouse Steven C.
  • INSIDER50d
    New insider Crouse Steven C. claimed ownership of 5,894 shares (SEC Form 3)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022